期刊档案 · 医学-毒理学

Human & Experimental Toxicology

ISSN 0960-3271 · eISSN 1477-0903 · SAGE Publications Inc. · ENGLAND · Monthly · 创刊 1990

Human & Experimental Toxicology 中科院 医学 4区(2025 年升级版),影响因子 3.56,完全开放获取,APC 约 2,800 美元,投稿社区反馈审稿约 2.3 个月,录用比例约51.66%(社区反馈),2025 年发文 71 篇,SCIE、Scopus 收录。

影响因子3.56LetPub 汇总的最新公布值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 3区
审稿周期约 2.3 个月投稿社区平均反馈
版面费2,800 USD完全开放获取
录用比例约51.66%投稿社区平均反馈
年发文量71 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Human & Experimental Toxicology 由 SAGE Publications Inc. 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Pesticide Exposure and Toxicity、Carcinogens and Genotoxicity Assessment、Poisoning and overdose treatments 等主题的论文,这 3 个主题约占 30.9%,主导子领域为 Health, Toxicology and Mutagenesis。(根据 OpenAlex 主题统计与中科院分区数据生成)

Human and Experimental Toxicology (HET), an international, peer-reviewed, open access journal, is dedicated to publishing nonclinical and clinical original research papers and in-depth reviews that comprehensively cover functional, biochemical, and structural disorders in toxicology. The principal aim of HET is to publish timely high impact hypothesis driven scholarly work with an international scope.The journal publishes on:Structural, functional, biochemical, and molecular effects of toxic agentsStudies that address mechanisms/modes of toxicitySafety evaluation of novel chemical, biotechnologically-derived products, and nanomaterials for human health assessment including statistical and mechanism-based approachesNovel methods or approaches to research on animal and human tissues (medical and veterinary patients) investigating the functional, biochemical, and structural disorderIn vitro techniques, particularly those supporting alternative methodsNovel approaches exploring e.g. adverse outcome pathways, also in the context of risk assessment of chemicalsPapers will be judged based on scientific originality and contribution to the field and quality and subject matter. Papers describing effects on humans or experimental animals only of local interests; it is important that the results can be generalized to wider audiences and applications. Authors must clearly identify chemically the material tested and briefly explain what novel toxic effect (s) or toxic mechanism (s) of the chemical is being reported and what their significance is.HET does not accept case reports and case studies. HET does not accept papers on herbal or other extracts unless sufficient chemical characterization of the material under investigation is supplied. HET does not publish routine toxicological studies without an aim to define novel mechanisms of toxicity. The same applies to studies that utilize excessive doses of chemicals/toxicants without any relevance with the human situation. Open access informationFrom January 2022, HET will become a fully open access journal. All articles that are accepted for publication will be subject to an open access article processing charge (APC) of $3200 and will be published with a Creative Commons license.The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.Submit your manuscript today at https://mc.manuscriptcentral.com/het.

摘自期刊官网 Aims & Scope

研究方向(LetPub):医学-毒理学

主编 Catherine Mary出版商官网

编委会国家分布:中国大陆 2 位(约 5%);主要国家 美国 15、印度 5、土耳其 3、马来西亚 3、中国 2(共 43 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Pesticide Exposure and ToxicityAgricultural and Biological Sciences10.8%
  2. Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology10.4%
  3. Poisoning and overdose treatmentsMedicine9.7%
  4. Heavy Metal Exposure and ToxicityEnvironmental Science7.4%
  5. Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics6.8%
  6. Effects and risks of endocrine disrupting chemicalsEnvironmental Science5.5%
  7. Animal testing and alternativesVeterinary4.1%
  8. Toxic Organic Pollutants ImpactEnvironmental Science3.5%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类毒理学TOXICOLOGY4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 3 区
类别学科分区
大类医学3 区
小类毒理学TOXICOLOGY3 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 4 区
类别学科分区
大类医学4 区
小类毒理学TOXICOLOGY4 区

Top 期刊:否综述期刊:否

数据库收录

SCIEScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
3.56LetPub ·
影响因子(出版商公布)
3.5出版商官网 ·
五年影响因子(出版商公布)
3.2出版商官网 ·
CiteScore 2026-06
7.1LetPub ·
SJR 2026-06
0.81LetPub ·
SNIP 2026-06
0.87LetPub ·
h-index
71LetPub ·
h-index
113OpenAlex ·
i10-index
2,892OpenAlex ·
两年平均被引
3.58OpenAlex ·
自引率
2.9%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
58LetPub ·

逐年发文量 OpenAlex 统计 · 累计 4,782 篇 · 当年数据不完整

年份发文量其中 OA被引
202625259
20257171150
20246767425
20231131131,134
20221531531,961
2021175532,687

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
平均2.3月LetPub ·
平均录用比例(社区反馈)
51.66%LetPub ·
录用率(出版商公布)
10.2%出版商官网 ·
投稿到首次决定
3 天出版商官网 ·
接收到发表
30 天出版商官网 ·
投稿到发表(期刊自报)
约 13 周DOAJ ·
评审方式
双盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 2,800有CC BY、CC BY-NC
OpenAlexUSD 2,800——
出版商官网USD 3,200——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点8 项,摘自作者指南
摘要
≤ 200 词
参考文献格式
Vancouver 格式
首次投稿格式
允许不按期刊格式排版(free format)
推荐审稿人
可选
Highlights(研究亮点)
必须提供
图文摘要
可选
投稿信(Cover letter)
必须提供
不接收
case studies/reports
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型6 种
  1. case studyView our Special Collections currently accepting submissions: https://journals.sagepub.com/page/het/call-for-papers/index. Please visit the Sage Journal Author …未说明篇幅
  2. mini-reviewsThe journal will publish both mini-reviews (abou未说明篇幅
  3. original researchView our Special Collections currently accepting submissions: https://journals.sagepub.com/page/het/call-for-papers/index. Please visit the Sage Journal Author …未说明篇幅
  4. reviewView our Special Collections currently accepting submissions: https://journals.sagepub.com/page/het/call-for-papers/index. Please visit the Sage Journal Author …未说明篇幅
  5. review articleView our Special Collections currently accepting submissions: https://journals.sagepub.com/page/het/call-for-papers/index. Please visit the Sage Journal Author …未说明篇幅
  6. review articlesReview articles The editors invite review articles on relevant and current topics in toxicology.未说明篇幅
出版商官网
官网政策摘录作者资格、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
作者资格 Author contributions

该期刊要求在投稿过程中列出每位作者的贡献,并在致谢部分之后加入“作者贡献”标题,该信息将在校对阶段显示。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

原文 ↗出版商官网 ·
数据可用性 Data availability

该期刊要求作者在相关公共数据存储库中共享研究数据,并包含一份数据可用性声明,说明数据是否可用及共享情况,或在某些情况下说明数据可用但未共享的原因。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. As a condition of publication authors are required to: Share your research data in a relevant public data repository Include a data availability statement. This sho…

原文 ↗出版商官网 ·
出版伦理 Ethical considerations

该期刊要求在指定标题下提供伦理批准声明,即使方法部分已包含相关信息;若无需伦理批准,须明确说明;涉及人类参与者、人类数据或人体组织的研究必须声明相关伦理委员会或机构审查委员会批准或豁免,并提供委员会全名、机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

原文 ↗出版商官网 ·
开放获取 Publishing fees and open access

该期刊为开放获取期刊,接受的文章在出版后立即免费在线发布,采用知识共享许可协议;稿件经同行评审被接受后须支付3200美元的一次性文章处理费,由资助者、机构或作者承担,投稿本身不收费。 模型中文摘要

Human & Experimental Toxicology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid …

原文 ↗出版商官网 ·
同行评审 Peer review policy

该期刊采用单盲同行评审,审稿人与编辑互动,不公布审稿信息;稿件先经初步评估,不符合指南要求的稿件将被退回修改,超出范围或不合适的稿件可能未经同行评审即被拒稿。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

原文 ↗出版商官网 ·
查重 Plagiarism

该期刊和Sage严肃对待版权侵权、抄袭或其他违反出版最佳实践的行为,并可能采取相应措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

原文 ↗出版商官网 ·
预印本 Preprints

该期刊接受已在预印本服务器上发布的稿件,投稿时须在指定字段输入预印本DOI,并建议告知编辑部;同行评审期间不应在预印本服务器上发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

原文 ↗出版商官网 ·
试验注册 / 报告规范 Clinical trial registration

该期刊遵循ICMJE要求,临床试验须在首个参与者入组时或之前在WHO认可的公共试验注册机构注册,作为考虑发表的先决条件,且须在摘要末尾提供注册机构名称、网址及注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
SAGE Publications Inc.
出版国家或地区
ENGLAND
出版语言
English
出版周期
Monthly
创刊年份
1990
ISSN
0960-3271
电子版 ISSN
1477-0903
官方链接

常见问题

关于 Human & Experimental Toxicology 的常见问题

Human & Experimental Toxicology 是中科院几区期刊?

2025 年升级版分区表中,Human & Experimental Toxicology 为医学 4区,小类 毒理学 4 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。

Human & Experimental Toxicology 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 3.56,CiteScore 为 7.1,h-index 为 113。

Human & Experimental Toxicology 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 2.3 个月,平均录用比例反馈为“约51.66%”;期刊官网公布的录用率为 10.2%。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Human & Experimental Toxicology 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 200 词;参考文献格式:Vancouver 格式;首次投稿格式:允许不按期刊格式排版(free format);推荐审稿人:可选;Highlights:必须提供;图文摘要:可选;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Human & Experimental Toxicology 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 43 位编委中,中国大陆 2 位(约 5%);人数最多的国家是 美国(15 位)、印度(5 位)、土耳其(3 位)。统计按编委会页面列出的机构国家计,仅供参考。

Human & Experimental Toxicology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Human & Experimental Toxicology 被 SCIE、Scopus、DOAJ 收录。

Human & Experimental Toxicology 是开放获取期刊吗?版面费多少?

Human & Experimental Toxicology 为完全开放获取。APC 约 2,800 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-28 归档)。最近更新:。